Revia

"A new report released by the Substance Abuse and Mental Health Services Administration (SAMHSA) shows that underage binge alcohol use rates vary extensively throughout the United States. The report shows that the levels of binge drinking in sub-"...

OVERDOSE

There is limited clinical experience with REVIA overdosage
in humans. In one study, subjects who received 800 mg daily REVIA for up to one
week showed no evidence of toxicity.

In the mouse, rat and guinea pig, the oral LD50s were
1,100 to 1,550 mg/kg; 1,450 mg/kg; and 1,490 mg/kg; respectively. High doses of
REVIA (generally ≥ 1,000 mg/kg) produced salivation, depression/reduced
activity, tremors, and convulsions. Mortalities in animals due to high-dose
REVIA administration usually were due to clonic-tonic convulsions and/or
respiratory failure.

Treatment of Overdosage

In view of the lack of actual experience in the treatment
of REVIA overdose, patients should be treated symptomatically in a closely
supervised environment. Physicians should contact a poison control center for
the most up-to-date information.